Fostemsavir for people with limited HIV treatment options
Part of Immune system & allergy, Infections clinical trials.
This program provides access to an investigational HIV medication called fostemsavir for people who have run out of standard options due to drug resistance or intolerance. It aims to help control the virus when other combinations fail.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be HIV positive and currently on antiretroviral therapy (ART) but with a high viral load (≥1000 copies/mL).
- You must have tried many HIV drugs and either developed resistance (the drugs stop working) or become intolerant to them, leaving you with few options.
- You must have no more than 2 other HIV drugs that are still fully active and can be combined with the study medication.
- If you are a woman who can become pregnant, you must agree to use reliable contraception and have negative pregnancy tests. If you are a man, you must use condoms with partners who can become pregnant and avoid donating sperm.
- You must not be taking certain medications that interfere with the study drug, such as rifampicin, St. John's wort, or certain seizure medicines.
- You must not have a history of consistently missing doses of your HIV medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study lets people who finished an earlier HIV treatment study keep getting the same medicine while a new trial is set up. It helps ensure you don't have a gap in your treatment.
This trial tests a new oral HIV medication (VH4524184) in people who have never taken HIV treatment before. It looks at how well the drug controls the virus and how safe it is.
This trial tests different ways to manage “virologic failure,” meaning HIV viral load stays high while taking TLD (a common HIV medicine combination). It may help people better control the virus and improve treatment results, especially in parts of sub-Saharan Africa.
This trial tests if a drug can lower inflammation in people with HIV who are on effective treatment. It may help reduce the risk of heart disease and other problems related to chronic inflammation.
This trial tests a drug called fostamatinib to see if it can help people with a severe lung condition called ARDS, which causes breathing failure. If you are in the hospital on a breathing machine, this drug might help your lungs recover.
This study tests whether switching to a medication called efavirenz can help control HIV. It is for people who have been on stable HIV treatment for years but still have low levels of virus in their blood.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.